These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6149687)

  • 1. Ocular beta-blockers and systemic effects.
    Van Buskirk EM; Fraunfelder FT
    Am J Ophthalmol; 1984 Nov; 98(5):623-4. PubMed ID: 6149687
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mode of action, clinical profile and significance of beta-blockers in antiglaucoma therapy].
    Schlote T
    Klin Monbl Augenheilkd; 2013 Feb; 230(2):120-6. PubMed ID: 23430677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular beta-blockers and systemic effects.
    Fraunfelder FT
    Arch Intern Med; 1986 Jun; 146(6):1073-4. PubMed ID: 2872865
    [No Abstract]   [Full Text] [Related]  

  • 4. Signs and symptoms of ocular surface status in glaucoma patients switched from timolol 0.5% to brinzolamide 1%/timolol 0.5% fixed combination: a 6-month efficacy and tolerability, multicenter, open-label prospective study.
    Rossi GC; Tinelli C; Pasinetti GM; Fusetti M; Pallavicini C; Stringa M; Vacchi S; Stringa F; Bianchi PE
    Expert Opin Pharmacother; 2011 Apr; 12(5):685-90. PubMed ID: 21385109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ophthalmic beta-blockers since timolol.
    Novack GD
    Surv Ophthalmol; 1987; 31(5):307-27. PubMed ID: 2885931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of beta blockers in open angle glaucoma.
    Marmion VJ
    Indian J Ophthalmol; 1982 Jul; 30(4):229-31. PubMed ID: 6131867
    [No Abstract]   [Full Text] [Related]  

  • 7. Short-term tolerability of once-daily timolol hemihydrate 0.5%, timolol maleate in sorbate 0.5%, and generic timolol maleate gel-forming solution 0.5% in glaucoma and/or ocular hypertension: a prospective, randomized, double-masked, active-controlled, three-period crossover pilot study.
    Sonty S; Mundorf TK; Stewart JA; Stewart WC
    Clin Ther; 2009 Oct; 31(10):2063-71. PubMed ID: 19922877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of aqueous instillation.
    MacKeen DL
    Ophthalmology; 1999 Oct; 106(10):1853. PubMed ID: 10519569
    [No Abstract]   [Full Text] [Related]  

  • 9. Fatal respiratory arrest following timolol ophthalmic solution.
    Malnick SD; Gelzer G; Attali M
    MedGenMed; 2001 Mar; 3(2):12. PubMed ID: 11549961
    [No Abstract]   [Full Text] [Related]  

  • 10. Contact allergy to beta-blocking agents in ophthalmic preparations.
    O'Donnell BF; Foulds IS
    Contact Dermatitis; 1993 Feb; 28(2):121-2. PubMed ID: 8096170
    [No Abstract]   [Full Text] [Related]  

  • 11. Latanoprost : an update of its use in glaucoma and ocular hypertension.
    Perry CM; McGavin JK; Culy CR; Ibbotson T
    Drugs Aging; 2003; 20(8):597-630. PubMed ID: 12795627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timolol and myasthenia gravis.
    Shaivitz SA
    JAMA; 1979 Oct; 242(15):1611-2. PubMed ID: 39182
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic and systemic side effects of ocular beta-adrenergic antagonists in anesthetized dogs.
    Svec AL; Strosberg AM
    Invest Ophthalmol Vis Sci; 1986 Mar; 27(3):401-5. PubMed ID: 2869005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contact dermatitis due to the beta-blocker befunolol [corrected] in eyedrops.
    Kanzaki T; Kato N; Kabasawa Y; Mizuno N; Yuguchi M; Majima A
    Contact Dermatitis; 1988 Nov; 19(5):388. PubMed ID: 2906845
    [No Abstract]   [Full Text] [Related]  

  • 15. [Efficacy and safety of substituting a twice-daily regimen of timolol with a single daily instillation of nonpreserved beta-blocker in patients with chronic glaucoma or ocular hypertension].
    Bron A; Chiambaretta F; Pouliquen P; Rigal D; Rouland JF
    J Fr Ophtalmol; 2003 Sep; 26(7):668-74. PubMed ID: 13130253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Local beta-blockers during pregnancy].
    Blaul G
    Klin Monbl Augenheilkd; 1981 Aug; 179(2):128-9. PubMed ID: 6127433
    [No Abstract]   [Full Text] [Related]  

  • 17. Fixed combinations of dorzolamide-timolol and brimonidine-timolol in the management of glaucoma.
    Razeghinejad MR; Sawchyn AK; Katz LJ
    Expert Opin Pharmacother; 2010 Apr; 11(6):959-68. PubMed ID: 20307220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What's in a name? New glaucoma drugs.
    Spratt A; Ogunbowale L; Wormald R; Franks W
    Lancet; 2006 Sep; 368(9538):826-7. PubMed ID: 16950343
    [No Abstract]   [Full Text] [Related]  

  • 19. Topical timolol therapy and cardiopulmonary function.
    Burggraf GW; Munt PW
    Can J Ophthalmol; 1980 Oct; 15(4):159-60. PubMed ID: 6108154
    [No Abstract]   [Full Text] [Related]  

  • 20. Brimonidine and timolol fixed-combination therapy versus monotherapy: a 3-month randomized trial in patients with glaucoma or ocular hypertension.
    Craven ER; Walters TR; Williams R; Chou C; Cheetham JK; Schiffman R;
    J Ocul Pharmacol Ther; 2005 Aug; 21(4):337-48. PubMed ID: 16117698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.